roztwór do wstrzykiwań clinical trials
4 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Subcutaneous Methotrexate, Oral Dexamethasone or Oral Montelukast for the Prevention of Infusion Related Reaction Associated with Amivantamab, an EGFR-MET bispecific antibody, Among Post-osimertinib Treated EGFRm NSCLC; SKIPPirr, a Phase 2 Study
This study looks at ways to prevent infusion reactions in people with advanced lung cancer receiving a new combination of medicines. Researchers are testing different medications given before treatment to see if they can reduce side effects when the main cancer drug is given through a drip.
For: EGFR-mutated Advanced or Metastatic Non-small Cell Lung CancerFrance · Spain - AuthorisedTherapeutic exploratory (Phase II)
A phase II efficacy and safety study of cell-free circulating tumor DNA-guided commencement of second-line treatment in patients with DLBCL/HGBCL relapse
This study looks at new ways to decide when to start a second treatment for certain types of lymphoma, using a blood test. It aims to see if this approach is safe and effective in helping patients.
For: Diffuse large B-cell lymphomas (DLBCL · Diffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCL · High-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiationPoland - AuthorisedPhase III and phase IV (Integrated)
Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial)
This study, called 'STOP CLOT', is looking at the best ways to use blood thinners during heart procedures like TEER or procedures to close a part of the heart called the left atrial appendage. It aims to prevent problems like blood clots and strokes.
For: periprocedural anticoagulant treatment in patients treated with TEER or transcatheter left atrial appendage closure surgeryPoland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Safety Outcomes Post Kidney Biopsy – randomized clinical Evaluation of Efficacy of Desmopressin
This study is looking at whether a medicine called desmopressin can help reduce bleeding after a kidney biopsy. Patients with rare kidney conditions are taking part to see if this treatment makes the procedure safer by preventing serious bleeding and other complications.
For: Rare and ultra-rare glomerulonephritisPoland